Literature DB >> 7502485

Interferon induction in peripheral blood mononuclear leukocytes of man and farm animals by poxvirus vector candidates and some poxvirus constructs.

M Büttner1, C P Czerny, K H Lehner, K Wertz.   

Abstract

Prototypes of three poxvirus genera--orthopoxvirus (OPV), parapoxvirus (PPV), avipoxvirus (APV)--and Newcastle disease virus (NDV) as a control, as well as three recombinant OPV strains and one recombinant APV strain, were incubated in vitro with peripheral blood mononuclear leukocytes (PBML) of man, sheep and swine. Antiviral activity was determined in PBML culture supernatants at different time intervals after virus cell interaction using a cytopathic effect inhibition bioassay. Additionally, supernatants derived from human PBML were screened for interferons (IFN) alpha and gamma as well as for tumor necrosis factor by enzyme-linked immunosorbent assay. IFN titers reached a maximum 24 h after PBML stimulation at a multiplicity of infection (MOI) greater than 1. IFN alpha/beta was found to be responsible for the antiviral effect. Using a MOI > or = 1 the highly attenuated strain MVA was the only representant of vaccinia virus (VV) that induced significant amounts of IFN also as a lacZ recombinant. Replicable virus from five well-known VV strains as well as the Chinese VV strain Tien Tan (VVTT) as a recombinant vaccine failed to induce leukocyte IFN. Inactivated VV strain Elstree and the recombinant TT strain induced high titers of leukocyte IFN. Supernatants derived from human, porcine and ovine PBML stimulated with replicable PPV, native VV MVA and MVA lacZ recombinant or native APV and APV lacZ recombinant virus regularly contained IFN alpha. In contrast to NDV, neither specific antisera nor monoclonal antibodies were able to block the INF induction by VV and PPV.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7502485     DOI: 10.1016/0165-2427(94)05357-x

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  20 in total

1.  Poxvirus-induced immunostimulating effects on porcine leukocytes.

Authors:  V Fachinger; T Schlapp; W Strube; N Schmeer; A Saalmüller
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  ORFV: a novel oncolytic and immune stimulating parapoxvirus therapeutic.

Authors:  Julia L Rintoul; Chantal G Lemay; Lee-Hwa Tai; Marianne M Stanford; Theresa J Falls; Christiano T de Souza; Byram W Bridle; Manijeh Daneshmand; Pamela S Ohashi; Yonghong Wan; Brian D Lichty; Andrew A Mercer; Rebecca C Auer; Harold L Atkins; John C Bell
Journal:  Mol Ther       Date:  2012-01-24       Impact factor: 11.454

3.  Selective induction of apoptosis in antigen-presenting cells in mice by Parapoxvirus ovis.

Authors:  N Kruse; O Weber
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  Deletion of major nonessential genomic regions in the vaccinia virus Lister strain enhances attenuation without altering vaccine efficacy in mice.

Authors:  Julie Dimier; Audrey Ferrier-Rembert; Karine Pradeau-Aubreton; Matthias Hebben; Danièle Spehner; Anne-Laure Favier; Danielle Gratier; Daniel Garin; Jean-Marc Crance; Robert Drillien
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

5.  Deletion of the vaccinia virus N2L gene encoding an inhibitor of IRF3 improves the immunogenicity of modified vaccinia virus Ankara expressing HIV-1 antigens.

Authors:  Juan García-Arriaza; Carmen E Gómez; Carlos Óscar S Sorzano; Mariano Esteban
Journal:  J Virol       Date:  2014-01-03       Impact factor: 5.103

6.  Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.

Authors:  Simone Hornemann; Olof Harlin; Caroline Staib; Sigrid Kisling; Volker Erfle; Bernd Kaspers; Georg Häcker; Gerd Sutter
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

7.  Conventional bone marrow-derived dendritic cells contribute to toll-like receptor-independent production of alpha/beta interferon in response to inactivated parapoxvirus ovis.

Authors:  Sabine Siegemund; Andrea Hartl; Heiner von Buttlar; Franziska Dautel; Rüdiger Raue; Marina A Freudenberg; György Fejer; Mathias Büttner; Gabriele Köhler; Carsten J Kirschning; Tim Sparwasser; Gottfried Alber
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

8.  Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses.

Authors:  Zoe Waibler; Martina Anzaghe; Holger Ludwig; Shizuo Akira; Siegfried Weiss; Gerd Sutter; Ulrich Kalinke
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

9.  Rapid expansion of CD8+ T cells in wild-type and type I interferon receptor-deficient mice correlates with protection after low-dose emergency immunization with modified vaccinia virus Ankara.

Authors:  Asisa Volz; Martin Langenmayer; Sylvia Jany; Ulrich Kalinke; Gerd Sutter
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

10.  Immunomodulatory effects of inactivated parapoxvirus ovis (ORF virus) on human peripheral immune cells: induction of cytokine secretion in monocytes and Th1-like cells.

Authors:  Astrid Friebe; Angela Siegling; Sonja Friederichs; Hans-Dieter Volk; Olaf Weber
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.